DANDRITE

Aarhus University Seal

SynuCa Therapeutics Secures 10M DKK for Drug Development

Spin‑out company SynuCa Therapeutics, founded in professor Poul Henning Jensen’s DANDRITE group and led by assistant professor Lasse Reimer as CEO, has secured 10 million DKK in new funding to advance their drug candidate toward clinical trials.

From left: CEO and founder Lasse Reimer, founder Claus Elsborg Olesen, founder Poul Henning Jensen, and founder and COO William Dalby Brown. | Photo: PR / Esben Zøllner Olesen for Bioinnovation Institute

Read the full article here: https://medwatch.dk/brancher/Medicinal___Biotek/article19073803.ece?utm_campaign=MedWatch%20Middag&utm_content=2026-03-09&utm_medium=email&utm_source=medwatch

Revised 16.07.2025
-
Rikke Skovgaard Lindhard